MarketsStocksVENMAX
VE

Venmax Drugs and Pharmaceuticals Ltd

NSE: VENMAXBSE: 531015Healthcare
Download Research Report7-page PDF
20.25
-3.53%
NSE · auto-updates while market open
Mkt Cap
₹24 Cr
P / E
121.5
P / B
1.7
ROE
2.2%
52W High
₹36.96
52W Low
₹19.01
Key Metrics
Market Cap
₹24 Cr
P / E
121.55
P / B
1.72
EV / EBITDA
193.76
ROCE
2.4%
ROE
2.2%
Debt / Equity
0.02
Book Value
₹12.19
EPS
₹0.21
Div Yield
0.0%
Face Value
-
Promoter Holding
13.8%
Revenue · ₹ Cr
0
FY20
0
FY21
2
FY22
0
FY23
0
FY24
1
FY25
8
FY26
Net Profit · ₹ Cr
2
0
0
0
0
0
0
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹3.5
₹0.4
₹0.1
₹0.2
₹-0.5
₹-0.5
₹-0.3
FY19FY20FY21FY22FY23FY24FY26
Q1 2026 snapshot
Sales
₹4 Cr
Operating profit
-
OPM
-
Net profit
₹0 Cr
EPS
₹0.21
Scorecard · 7 axes
Quality
Weak
37/100
Valuation
Bad
121.5×
Growth
Avg
+7.1%
Profitability
Bad
2.3%
Performance
Bad
-12.5%
Entry Point
Strong
55%
Red Flags
Strong
0 flags
Shareholding Pattern
13.8%Promoter
Promoter13.8%
Public86.2%
Quarterly Results · ₹ Cr
QuarterFY21 09QFY21 12QFY22 06QFY22 09QFY22 12QFY23 09Q
Revenue005,00,0005,00,0005,00,0000
Net Profit-3,42,000-3,41,0002,97,000-1,49,0001,81,200-0.028
NPM %--59.4%-29.8%36.2%-
AlertPre-trade